Kevin Trapp
Chief Commercial Officer (CCO) at DBV Technologies NASDAQ:DBVT | New York City Metropolitan Area, United States
- In role
- 11m
- At DBV Technologies…
- 11m
- Total exp.
- 36y 1m
- Job change risk
- Low
- Seniority tier
- C-Suite / Owner
- Data Confidence
- 90%
DBV Technologies NASDAQ:DBVT Nov 2025 – Present · 11m
- Chief Commercial Officer (CCO)
Biotech Value Advisors Apr 2022 – Nov 2025 · 3y 8m
- Managing Director
DBV Technologies Feb 2017 – Mar 2021 · 4y 2m
- Senior Advisor Oct 2020 – Mar 2021 · 6m
- Chief Commercial Officer Aug 2018 – Oct 2020 · 2y 3m Promoted
- Senior Advisor Feb 2017 – Jul 2018 · 1y 6m
Bristol-Myers Squibb Feb 1989 – Jun 2016 · 27y 5m
- SVP, Head Product, Portfolio & Access Strategy May 2015 – Jun 2016 · 1y 2m
- SVP, Head of Access Strategy, Worldwide Commercialization Jun 2014 – May 2015 · 1y
- SVP Global Commercialization - Virology/Neuroscience Jun 2013 – Aug 2014 · 1y 3m
- SVP, Neuroscience, Immunoscience & Virology Oct 2010 – Jun 2013 · 2y 9m Promoted
- Vice President Commercial Operations, Neuroscience Nov 2009 – Oct 2010 · 1y
- Vice President, Neuroscience Sales Jul 2008 – Nov 2009 · 1y 5m
- Vice President Marketing - Neuroscience Mar 2006 – Jul 2008 · 2y 5m Promoted
- Sr. Director, Strategy & Ops - Virology Jan 1999 – Mar 2006 · 7y 3m Promoted
- Various Accounting and Finance Roles Feb 1989 – Jan 1999 · 10y
- Function
- Sales
- Seniority tier
- C-Suite / Owner
- Budget influence
-
High
Chief Commercial Officer with extensive executive leadership experience.
- Market influence
- 1 of 3,157 Chief Commercial Officer (CCO) profiles in United States
Life Sciences | McKinsey Alum | Commercial Strategy | Business Development
BVA is a biotech advisor and investor based firm. We augment and support CCO and Head of BD initiatives, typically on a fractional basis, for innovative biotech companies.
BioPharma Board Director
Clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells. We are currently developing our multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
High impact builder of teams and brands to deliver innovative healthcare solutions to patients
Managing Director at Biotech Value Advisors
(Aug 2024 – Present)
Pharmaceutical Leader
Biotech Value Advisors (BVA) delivers cross-functional new product planning, commercialization and corporate development support that creates value for biotech partners. We act as, or supplement, your commercial or executive leadership team.
Senior executive biopharma professional Global/US leader with experience across multiple therapeutic and functional areas including R&D, Regulatory, BD&L, Medical Affairs , New Product Development and Commercialization.
Head of Medical Affairs at Biotech Value Advisors
(Sep 2019 – Present)
Experienced Pharmaceutical Executive
Managing Director Europe at Biotech Value Advisors
(Nov 2022 – Present)
What is Kevin Trapp email address?
Email Kevin Trapp at [email protected] and [email protected]. This email is the most updated Kevin Trapp's email found in 2026.
How to contact Kevin Trapp?
To contact Kevin Trapp send an email at [email protected] or [email protected].
What company does Kevin Trapp work for?
Kevin Trapp works for DBV Technologies NASDAQ:DBVT.
What is Kevin Trapp's role at DBV Technologies NASDAQ:DBVT?
Kevin Trapp is Chief Commercial Officer (CCO)
